(Q43825196)

English

Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium

scientific article published in November 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium (English)

1 reference

Europe PubMed Central

27 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Polek TC

1

1 reference

Europe PubMed Central

27 November 2017

Murthy S

2

1 reference

Europe PubMed Central

27 November 2017

Blutt SE

3

1 reference

Europe PubMed Central

27 November 2017

Boehm MF

4

1 reference

Europe PubMed Central

27 November 2017

Zou A

5

1 reference

Europe PubMed Central

27 November 2017

Weigel NL

6

1 reference

Europe PubMed Central

27 November 2017

Allegretto EA

7

1 reference

Europe PubMed Central

27 November 2017

publication date

1 November 2001

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

49

1 reference

Europe PubMed Central

27 November 2017

3

1 reference

Europe PubMed Central

27 November 2017

224-233

1 reference

Europe PubMed Central

27 November 2017

Basic and clinical concepts related to vitamin D metabolism and action (second of two parts).

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Possible role for vitamin D in controlling breast cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Combined effects of 1,25-dihydroxyvitamin D3 and tamoxifen on the growth of MCF-7 and ZR-75-1 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

A protective role of 1,25-dihydroxyvitamin D3 in chemically induced rat colon carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Topical calcipotriol treatment in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Studies on the human prostatic cancer cell line LNCaP.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

p53 oncogene mutations in three human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

PAP and PSA in prostatic carcinoma cell lines and aspiration biopsies: relation to hormone sensitivity and to cytological grading

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

From ligand to response: generating diversity in nuclear receptor coregulator function.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Flutamide: an antiandrogen for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Tamoxifen in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice

1 reference

https://api.crossref.org/works/10.1002%2FPROS.1138

21 January 2018

Identifiers

10.1002/PROS.1138

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43825196&oldid=2126080347"